amaxa - Part of the Lonza Group

Check out amaxa's databases

amaxa news #11 has just been released. Have a look or directly download it as PDF [1.4 MB].


   Subscribe to amaxa eNews
   Subscribe to RSS Feeds
   What is RSS?


Nucleofector Technology - in single & high-throughput mode

Nucleofection - a revolution in transfection:
From Nucleofection to protein expression in just a few hours. Read more...

The Basic 96-well Nucleofector Kits for Human Cells are designed for high throughput transfection using your human embryonic stem cell line of interest.
> Read more...

Peptide Transfection is Easy!

Nucleofector Technology now delivers peptides, as well as nucleic acids, with great efficiency. 

The > Amaxa Peptide Transfection Control offers an easy way to begin your peptide transfections!

www.lonza.com

Lonza Group (SWX:Lonn) announces that it has completed the acquisiton of amaxa as of 2 July 2008. This deal significantly strengthens the Cell Discovery business of Lonza  by complementing and expanding the existing portfolio.

> Read more...